Analysis

Carnival Corporation to report Q4 earnings on Dec. 19. Here’s what to expect

When Carnival Corporation (NYSE: CCL) reports its fourth-quarter results on Friday, investors will be closely watching demand trends, pricing, and cost discipline,

General Mills (GIS) aims to generate double-digit sales growth from new products in FY2026

Shares of General Mills, Inc. (NYSE: GIS) gained over 2% on Wednesday after the company posted better-than-expected earnings results for the second

Paychex expected to report higher revenue and earnings for Q2 FY26

Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY

Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales

December 18, 2025

CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates

Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings

December 18, 2025

ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results

Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a

December 18, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top